Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers
2 Articles
2 Articles
A study is based on previous research on “supermobilizers”
Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers
Abstract Alzheimer’s disease (AD) develops silently for years before symptoms emerge, making early identification of at-risk individuals essential for prevention trials and early intervention. We tested whether combining neurophysiological, imaging, and blood biomarkers improves prediction of progression to mild cognitive impairment (MCI) in cognitively unimpaired older adults with a family history of AD ( n = 102; 31 progressors; mean follow-up…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium

